JPH11180832A - Composition for scalp and hair - Google Patents

Composition for scalp and hair

Info

Publication number
JPH11180832A
JPH11180832A JP36340097A JP36340097A JPH11180832A JP H11180832 A JPH11180832 A JP H11180832A JP 36340097 A JP36340097 A JP 36340097A JP 36340097 A JP36340097 A JP 36340097A JP H11180832 A JPH11180832 A JP H11180832A
Authority
JP
Japan
Prior art keywords
composition
scalp
hair
acid
scalp hair
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP36340097A
Other languages
Japanese (ja)
Inventor
Toshisuke Takeda
俊祐 武田
Yoshiharu Tsuji
善春 辻
Masaaki Uemura
雅明 植村
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shiseido Co Ltd
Original Assignee
Shiseido Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shiseido Co Ltd filed Critical Shiseido Co Ltd
Priority to JP36340097A priority Critical patent/JPH11180832A/en
Publication of JPH11180832A publication Critical patent/JPH11180832A/en
Withdrawn legal-status Critical Current

Links

Landscapes

  • Cosmetics (AREA)

Abstract

PROBLEM TO BE SOLVED: To obtain the subject composition having excellent depilation preventing effects, dandruff and itch preventing effects on scalp and excellent safety by including acetylated hyaluronic acid and an antiphlogistic. SOLUTION: This composition comprises (A) 0.001-10 wt.% (based on the total of the composition, hereinafter in the same way), preferably 0.01-5 wt.% of acetylated hyaluronic acid, (B) 0.001-5 wt.%, preferably 0.01-3 wt.% of an antiphlogistic and (C) optionally an oil component, a surfactant, a humectant, a thickening agent, a perfume, a coloring matter, a solvent, etc. The number of substitution of acetyl groups of the component A is preferably 2-4 on the average in a repeating unit of the formula (R<1> to R<4> are each H or an acetyl subjected to ester bond and two or more of R<1> to R<4> are acetyl on the average in each repeating structure; R<5> is H or an alkali metal. Glycyrrhetic acid (derivative), salicylic acid (derivative) or the like is preferably used as the component B.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明は頭皮頭髪用組成物に
関する。さらに詳しくは優れた脱毛防止効果及びフケ・
カユミ防止効果を有する頭皮頭髪用組成物に関する。
TECHNICAL FIELD The present invention relates to a composition for scalp hair. More specifically, it has an excellent hair loss prevention effect and dandruff
The present invention relates to a scalp hair composition having a Kayumi prevention effect.

【0002】[0002]

【従来の技術】頭皮頭髪用組成物には様々な種類があ
り、様々な頭皮頭髪状態に対応した製品が毛髪化粧料、
育毛剤等として開発されている。例えば、頭皮における
フケやカユミを防止することにより脱毛を防止する製品
が開発されている。
2. Description of the Related Art There are various types of scalp hair compositions, and products corresponding to various scalp hair conditions are hair cosmetics,
It has been developed as a hair restorer and the like. For example, products have been developed that prevent hair loss by preventing dandruff and Kayumi on the scalp.

【0003】頭皮における様々なトラブルは、高齢化社
会を迎えた今日では社会的ストレスの増大も伴って増加
しつつあり、頭皮におけるトラブルに対応した頭皮頭髪
化粧料の需要は急増している。
[0003] In today's aging society, various troubles on the scalp are increasing along with an increase in social stress, and the demand for scalp hair cosmetics corresponding to troubles on the scalp is rapidly increasing.

【0004】一般に、頭部の禿や脱毛、毛の細り、頭皮
のフケやカユミ等の原因としては、毛根の皮脂腺等の器
官における男性ホルモンの活性化、過剰な皮脂分泌、過
酸化脂質の生成、毛包への血流量の低下及びストレス等
が挙げられる。
In general, baldness and alopecia of the head, thinning of hair, dandruff and kayumi of the scalp are caused by activation of androgens in organs such as sebaceous glands of hair root, excessive sebum secretion, and production of lipid peroxide. And a decrease in blood flow to the hair follicle and stress.

【0005】また、丈夫で美しい髪を育てるうえで、十
分な毛包への栄養補給が出来ない場合、細毛ややせ毛の
原因となる。また、毛包への血流量の低下は、栄養不足
や老廃物の排泄の機能の低下を招く結果となる。
[0005] In addition, when sufficient nutrition is not supplied to hair follicles for growing durable and beautiful hair, fine hair and thin hair may be caused. Also, a decrease in blood flow to the hair follicle results in a lack of nutrition and a reduced function of excreting waste products.

【0006】このような観点から、頭皮における角質層
のターンオーバーや過剰な皮脂分泌等を改善すること
は、少なくとも頭皮における血流機能の低下を改善する
ことと共に、頭皮及び頭髪のトラブルを解決する上で欠
かせないポイントとなる。
[0006] From such a point of view, improving turnover of the stratum corneum and excessive sebum secretion in the scalp solves at least a decrease in blood flow function in the scalp and solves problems in the scalp and hair. It is an indispensable point on the top.

【0007】従来の頭皮頭髪用組成物は一般に、これら
の禿や脱毛の原因と考えられる要素を取り除いたり軽減
する作用を持つ物質を配合したものである。例えば、ビ
タミンB、ビタミンE等のビタミン類、セリン、メチオ
ニン等のアミノ酸類、センブリエキス、アセチルコリン
誘導体などの血管拡張剤、紫根エキス等の抗炎症剤、エ
ストラジオール等の女性用ホルモン剤、セファランチン
などの皮膚機能亢進剤等が配合され、禿や脱毛、髪の細
りの予防および治療に用いられている。
[0007] Conventional scalp hair compositions generally contain a substance having an action of removing or reducing the factors considered to be the cause of baldness and hair loss. For example, vitamins such as vitamin B and vitamin E, amino acids such as serine and methionine, assembly extracts, vasodilators such as acetylcholine derivatives, anti-inflammatory agents such as purple root extract, hormonal agents for women such as estradiol, cepharanthin and the like It contains a skin function enhancer and the like, and is used for preventing and treating baldness, hair loss, and hair thinning.

【0008】[0008]

【発明が解決しようとする課題】しかしながら、これら
に成分を少量のみ頭皮頭髪用組成物中に配合しても十分
な効果を得ることは難しく、逆に多く配合すると使用部
分およびその周辺に深いな刺激感や発赤を伴う傾向が強
まるためその配合量には制限があり必ずしも所望の効果
が充分に得られないといった問題点があった。
However, it is difficult to obtain a sufficient effect even if only a small amount of these components is incorporated into the scalp hair composition. Since the tendency to accompany irritation and redness increases, there is a problem that the compounding amount is limited and a desired effect cannot always be sufficiently obtained.

【0009】本発明者等は上述の観点に鑑み鋭意研究を
重ねた結果、アセチル化ヒアルロン酸と特定の消炎剤と
を組み合わせて配合することにより、優れた脱毛防止効
果と頭皮のフケ・カユミ防止効果を有しかつ安全性にも
優れる頭皮頭髪用組成物が得られることを見出し本発明
を完成するに至った。
The inventors of the present invention have conducted intensive studies in view of the above-mentioned viewpoints. As a result, the combination of acetylated hyaluronic acid and a specific anti-inflammatory agent results in an excellent hair loss preventing effect and dandruff / kayumi prevention on the scalp. The present inventors have found that a composition for scalp hair which has an effect and is excellent in safety can be obtained, and has completed the present invention.

【0010】本発明は優れた脱毛防止効果と頭皮のフケ
・カユミ防止効果を有しかつ安全性にも優れる頭皮頭髪
用組成物を提供することを目的とする。
It is an object of the present invention to provide a composition for scalp hair which has an excellent effect of preventing hair loss and an effect of preventing dandruff and swelling of the scalp and is also excellent in safety.

【0011】[0011]

【課題を解決するための手段】すなわち、本発明は、ア
セチル化ヒアルロン酸と消炎剤とを含有することを特徴
とする頭皮頭髪用組成物を提供するものである。
That is, the present invention provides a composition for scalp hair, which comprises acetylated hyaluronic acid and an anti-inflammatory agent.

【0012】また、本発明は、前記アセチル化ヒアルロ
ン酸のアセチル基の置換数が、下記化学式「化2」で表
される繰り返し構造単位において平均して2〜4である
ことを特徴とする前記の頭皮頭髪用組成物を提供するも
のである。
Further, the present invention is characterized in that the acetylated hyaluronic acid has an average of 2 to 4 substitutions of an acetyl group in the repeating structural unit represented by the following chemical formula (Formula 2). And a composition for scalp hair.

【化2】 (式中、R1、R2、R3、R4は水素またはエステル結合
されたアセチル基を意味し、且つ平均して各繰り返し構
造においてR1〜R4の少なくとも2以上がアセチル基で
ある。R5は水素またはアルカリ金属原子を示す。)
Embedded image (Wherein, R 1 , R 2 , R 3 , and R 4 each represent hydrogen or an acetyl group bonded through an ester bond, and on average, at least two or more of R 1 to R 4 in each repeating structure are acetyl groups. R 5 represents hydrogen or an alkali metal atom.)

【0013】さらに、本発明は、前記消炎剤が、グリチ
ルレチン酸及びその誘導体、グリチルリチン酸及びその
誘導体、サリチル酸及びその誘導体、オクトピロック
ス、酸化亜鉛、アラントイン、塩化ベンザルコニウム、
イソプロピルメチルフェノール、メントールからなる群
から選ばれた一種または二種以上であることを特徴とす
る前記の頭皮頭髪用組成物を提供するものである。
[0013] Further, the present invention provides the anti-inflammatory agent, wherein the anti-inflammatory agent is glycyrrhetinic acid and its derivative, glycyrrhizic acid and its derivative, salicylic acid and its derivative, octopirox, zinc oxide, allantoin, benzalkonium chloride,
The composition for scalp hair is one or more selected from the group consisting of isopropylmethylphenol and menthol.

【0014】また、本発明は、前記アセチル化ヒアルロ
ン酸の含有量が頭皮頭髪用組成物全量に対して0.00
1〜10重量%であることを特徴とする前記の頭皮頭髪
用組成物を提供するものである。
[0014] The present invention also relates to the present invention, wherein the content of the acetylated hyaluronic acid is 0.00% to the total amount of the scalp hair composition.
1 to 10% by weight of the composition for scalp hair.

【0015】さらに、本発明は、前記消炎剤の含有量が
頭皮頭髪用組成物全量に対して0.001〜5重量%で
あることを特徴とする前記の頭皮頭髪用組成物を提供す
るものである。
Further, the present invention provides the above composition for scalp hair, wherein the content of the anti-inflammatory agent is 0.001 to 5% by weight based on the total amount of the composition for scalp hair. It is.

【0016】[0016]

【発明の実施の形態】以下、本発明の構成について詳述
する。
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS The configuration of the present invention will be described below in detail.

【0017】本発明に用いるアセチル化ヒアルロン酸
は、ヒアルロン酸の水酸基を部分的にアセチル化した高
分子化合物であり、水酸基に対するアセチル化率は特に
限定されないが、下記一般式「化3」で表される繰り返
し構造単位においてアセチル基の置換数が平均して2〜
4のものが好ましい。
The acetylated hyaluronic acid used in the present invention is a high molecular compound in which the hydroxyl group of hyaluronic acid is partially acetylated. The acetylation rate for the hydroxyl group is not particularly limited, but is represented by the following general formula [Chemical Formula 3]. The number of substitution of the acetyl group in the repeating structural unit is 2 to 2 on average
Four are preferred.

【化3】 (式中、R1、R2、R3、R4は水素またはエステル結合
されたアセチル基を意味し、且つ平均して各繰り返し構
造においてR1〜R4の少なくとも2以上がアセチル基で
ある。R5は水素またはアルカリ金属原子を示す。)
Embedded image (Wherein, R 1 , R 2 , R 3 , and R 4 each represent hydrogen or an acetyl group bonded through an ester bond, and on average, at least two or more of R 1 to R 4 in each repeating structure are acetyl groups. R 5 represents hydrogen or an alkali metal atom.)

【0018】アセチル化ヒアルロン酸の製造方法は、例
えば、粉末状のヒアルロン酸を酢酸に分散し触媒として
無水トリフルオロ酢酸を加て反応させる方法や、酢酸に
分散しp−トルエンスルホン酸を加えさらに無水酢酸を
加えて反応させる方法、あるいは無水酢酸溶媒に懸濁さ
せ濃硫酸を加えて反応させる方法等が知られている(特
開平6−9707号公報、特開平8−53501号公報
参照)。
The method for producing acetylated hyaluronic acid includes, for example, a method in which powdery hyaluronic acid is dispersed in acetic acid and reacted by adding trifluoroacetic anhydride as a catalyst, or a method in which p-toluenesulfonic acid is dispersed in acetic acid and p-toluenesulfonic acid is added. A method of reacting by adding acetic anhydride or a method of suspending in acetic anhydride solvent and adding concentrated sulfuric acid to react is known (see JP-A-6-9707 and JP-A-8-53501).

【0019】本発明に用いるアセチル化ヒアルロン酸の
配合量は、頭皮頭髪用組成物全量に対して、通常、0.
001〜10重量%、好ましくは0.01〜5重量%で
ある。0.001重量%未満では十分な脱毛防止や頭皮
のフケ・カユミ防止効果が得られず、また、10重量%
を超えると頭皮に不快なべたつき感を与える場合があ
る。
The amount of acetylated hyaluronic acid to be used in the present invention is usually 0.1% based on the total amount of the composition for scalp and hair.
001 to 10% by weight, preferably 0.01 to 5% by weight. If the amount is less than 0.001% by weight, sufficient hair loss prevention effect and dandruff / kayumi prevention effect on the scalp cannot be obtained, and 10% by weight.
Exceeding the scalp may give an unpleasant sticky feeling.

【0020】本発明に用いる消炎剤は、例えば、グリチ
ルレチン酸及びその誘導体、グリチルリチン酸及びその
誘導体、サリチル酸及びその誘導体、オクトピロック
ス、酸化亜鉛、アラントイン、塩化ベンザルコニウム、
イソプロピルメチルフェノール、メントール等が挙げら
れ、本発明においては、これらの一種または二種以上が
好ましく用いられる。
The anti-inflammatory agent used in the present invention includes, for example, glycyrrhetinic acid and its derivatives, glycyrrhizic acid and its derivatives, salicylic acid and its derivatives, octopirox, zinc oxide, allantoin, benzalkonium chloride,
Examples thereof include isopropylmethylphenol and menthol, and in the present invention, one or more of these are preferably used.

【0021】本発明に用いる消炎剤の配合量は、頭皮頭
髪用組成物全量に対して、通常、0.001〜5重量
%、好ましくは0.01〜3重量%である。0.001
重量%未満では十分な脱毛防止や頭皮のフケ・カユミ防
止効果が得られず、また、5重量%を超えると製剤上配
合が困難になったり、頭皮に不快な刺激感を与える場合
があるので好ましくない。
The amount of the anti-inflammatory agent used in the present invention is usually 0.001 to 5% by weight, preferably 0.01 to 3% by weight, based on the total amount of the scalp hair composition. 0.001
If the content is less than 5% by weight, sufficient hair loss prevention and scalp dandruff / kayumi prevention effects cannot be obtained. If the content is more than 5% by weight, it may be difficult to formulate the composition or give an unpleasant irritation to the scalp. Not preferred.

【0022】本発明の頭皮頭髪用組成物は、上記した必
須成分の他に、本発明の効果を損なわない範囲で、通常
化粧料に用いられる他の成分、例えば、油分、界面活性
剤、保湿剤、増粘剤、紫外線吸収剤、酸化防止剤、防腐
剤、香料、色素、水、アルコール等の溶媒を必要に応じ
て適宜配合し目的とする剤形に応じて常法により製造す
ることができる。
The composition for scalp and hair of the present invention contains, in addition to the above-mentioned essential components, other components usually used in cosmetics, such as oils, surfactants, and moisturizers, as long as the effects of the present invention are not impaired. It can be manufactured by a conventional method according to the desired dosage form by appropriately mixing a solvent such as an agent, a thickener, an ultraviolet absorber, an antioxidant, an antiseptic, a fragrance, a pigment, water, and an alcohol as needed. it can.

【0023】本発明の頭皮頭髪用組成物とは、化粧料、
医薬品、医薬部外品として頭皮または頭髪に適用する外
用剤で、その剤型は任意であり、例えば、液状、乳液、
軟膏、クリーム、ゲル、エアゾールなど外用に適用可能
な剤型のものであればいずれでもよく、例えば、トニッ
ク、スカルプトリートメント等の形態で用いられる。
The composition for scalp hair of the present invention includes cosmetics,
Pharmaceutical, an external preparation applied to the scalp or hair as a quasi-drug, its dosage form is arbitrary, for example, liquid, emulsion,
Ointments, creams, gels, aerosols, and other dosage forms that can be applied externally may be used. For example, they are used in the form of tonics, scalp treatments, and the like.

【0024】[0024]

【実施例】次に、実施例を挙げて本発明を更に詳しく説
明するが本発明はこれらの実施例のみに限定されるもの
ではない。なお、以下の実施例において配合量は重量%
である。
Next, the present invention will be described in more detail with reference to examples, but the present invention is not limited to these examples. In addition, in the following examples, the compounding amount is% by weight.
It is.

【0025】「表1」及び「表2」に示す実施例及び比
較例について、以下の試験及び評価方法により脱毛効果
及びフケ・カユミ防止効果について検討した。その結果
を「表3」及び「表4」に示す。
With respect to the examples and comparative examples shown in Tables 1 and 2, the hair removal effect and the dandruff / kayumi prevention effect were examined by the following tests and evaluation methods. The results are shown in “Table 3” and “Table 4”.

【0026】「脱毛防止効果試験」実施例及び比較例の
試料(ローション)使用前後の洗髪による脱毛本数の変
化を測定した。被験者は男性で、比較例および実施例各
群10名とした。試験期間は6ヶ月間とし、前期の2ヶ
月間は試料無塗布の期間、後期4ヶ月間を試料塗布期間
とした。試料塗布期間には、試料を1日2回、1回につ
き2〜4mlを頭皮に塗布した。試験期間中には、1日
おきに洗髪して抜け毛を回収し、1週間分をまとめてそ
の終毛の本数を数えた。抜け毛数の評価は、試料塗布期
間の洗髪1回あたりの抜け毛本数を用い、前期最終週平
均値と後期最終週平均値を比較した。この結果を以下の
基準により判定し、+以上の被験者割合が50%以上の
場合を有効とし、その他は無効として評価した。 (判定基準) ++:抜け毛本数が70本以上減少しており著しい効果
を認めた。 +:抜け毛本数が40本以上減少しておりかなり効果を
認めた。 ±:抜け毛本数が10本以上減少しておりやや効果を認
めた。 −:抜け毛本数が10本未満の減少または抜け毛数の増
加があり効果は認められなかった。
"Test for the effect of preventing hair loss" The change in the number of hair loss due to hair washing before and after using the samples (lotions) of the examples and comparative examples was measured. The test subjects were male, and each of the comparative example and the example was 10 persons in each group. The test period was six months, the first two months were the period of no sample application, and the last four months were the sample application period. During the sample application period, 2 to 4 ml of the sample was applied to the scalp twice a day. During the test period, the hair was washed every other day to collect the hair loss, and the number of end hairs was counted for one week. The number of hair loss was evaluated by using the number of hair loss per hair washing during the sample application period, and the average value of the last week in the first half and the average value of the last week in the second half were compared. The results were judged according to the following criteria. A case where the proportion of subjects with + or more was 50% or more was evaluated as valid, and the others were evaluated as invalid. (Evaluation criteria) ++: The number of hair loss decreased by 70 or more, and a remarkable effect was recognized. +: The number of hair loss was reduced by 40 or more, and a considerable effect was recognized. ±: The number of hair loss was reduced by 10 or more, and a slight effect was recognized. -: The number of hair loss was less than 10 or the number of hair loss increased, and no effect was observed.

【0027】「フケ・カユミ防止効果試験」特にフケ・
カユミを訴える男性を対象とし、比較例および実施例各
群10名について試験終了後のフケ・カユミについて調
査し、フケ中のタンパク質量とカユミの程度によって評
価した。試料塗布期間は3ヶ月とし、この間薬剤無添加
のシャンプーで1日1回洗髪し、試料を1日2回、1回
につき2〜4mlを頭皮に塗布した。試験終了時に、被
験者より洗髪前に吸引装置により頭部フケを採取し、フ
ケ中のタンパク質量を測定してその平均値を平均フケ量
として評価した。また各被験者に対し頭皮のカユミにつ
いて調査し、その程度を以下の基準に従い判定しその平
均値で評価した。 (判定基準) 3:強いカユミがある。 2:カユミがある。 1:ややカユミがある。 0:カユミはない。
"Test for the effect of preventing dandruff and Kayumi"
A group of 10 men in each of the comparative example and the example were investigated for dandruff / kayumi after the test, and evaluated based on the amount of protein in dandruff and the degree of kayumi. The sample application period was three months. During this period, the hair was washed once a day with a shampoo containing no drug, and the sample was applied twice a day to the scalp twice a day. At the end of the test, head dandruff was collected from the subject with a suction device before washing the hair, the amount of protein in the dandruff was measured, and the average value was evaluated as the average dandruff amount. In addition, each subject was examined for scalp Kayumi, the degree was determined according to the following criteria, and the average was evaluated. (Judgment criteria) 3: There is strong Kayumi. 2: There is Kayumi. 1: There is a little Kayumi. 0: There is no Kayumi.

【0028】[0028]

【表1】 [Table 1]

【表2】 [Table 2]

【0029】「製造方法」95%エタノールに、アセチ
ル化ヒアルロン酸、消炎剤、グリセリン、POE硬化ヒ
マシ油(100モル付加)、香料を溶解させた。次に、
精製水にリンゴ酸、色素を溶解させ、エタノール部に加
えた後、撹拌させ透明液状のローションを得た。
[Production method] Acetylated hyaluronic acid, an anti-inflammatory agent, glycerin, POE hydrogenated castor oil (100 mol added), and a fragrance were dissolved in 95% ethanol. next,
Malic acid and a dye were dissolved in purified water, added to the ethanol part, and then stirred to obtain a transparent liquid lotion.

【0030】[0030]

【表3】 [Table 3]

【表4】 [Table 4]

【0031】「表3」及び「表4」から明らかなように
本発明の実施例は脱毛防止効果に優れかつフケ・カユミ
防止効果に優れていた。
As is clear from Tables 3 and 4, the examples of the present invention were excellent in the effect of preventing hair loss and the effect of preventing dandruff and kayumi.

【0032】以下に本発明のその他の実施例を示すが、
いずれの実施例も脱毛防止、フケ・カユミ防止効果及び
安全性に優れ、安定性にも優れるものであった。
Hereinafter, other embodiments of the present invention will be described.
All of the examples were excellent in the effect of preventing hair loss, the effect of preventing dandruff and Kayumi, the safety, and the stability.

【0033】 「実施例11:ローション」 配合成分 重量% 95%エタノール 55.0 アセチル化ヒアルロン酸 2.0 グリチルレチン酸 0.5 オクトピロクス 0.2 1,3−ブチレングリコール 2.0 POE硬化ヒマシ油(60モル付加) 1.0 コハク酸 適量 香料および色素 適量 精製水 残分 製造方法:95%エタノールにアセチル化ヒアルロン酸
を溶解させ、グリチルレチン酸、オクトピロックス、
1,3−ブチレングリコール、POE硬化ヒマシ油(60
モル付加)、香料を溶解させた。次に、精製水にコハク
酸、色素を溶解させ、エタノール部に加えた後、撹拌さ
せ透明液状のローションを得た。
“Example 11: Lotion” Ingredients Weight% 95% Ethanol 55.0 Acetylated Hyaluronic Acid 2.0 Glycyrrhetinic Acid 0.5 Octopirox 0.2 1,3-butylene glycol 2.0 POE hydrogenated castor oil ( 1.0 Succinic acid Appropriate amount Fragrance and pigment Appropriate amount Purified water residue Production method: Dissolve acetylated hyaluronic acid in 95% ethanol, and add glycyrrhetinic acid, octopirox,
1,3-butylene glycol, POE hydrogenated castor oil (60
Mol addition) and the fragrance was dissolved. Next, succinic acid and a dye were dissolved in purified water, added to the ethanol part, and stirred to obtain a transparent liquid lotion.

【0034】 「実施例12:ローション」 配合成分 重量% 95%エタノール 75.0 アセチル化ヒアルロン酸 0.3 グリチルリチン酸ジカリウム 3.0 アラントイン 0.2 サリチル酸 0.01 ジプロピレングリコール 1.0 POE(24モル)・POP(13モル)テ゛シルテトラテ゛シルエーテル 0.5 乳酸 適量 乳酸ナトリウム 適量 香料および色素 適量 精製水 残分 製造方法:95%エタノールにアセチル化ヒアルロン酸
を溶解させ、グリチルリチン酸ジカリウム、アラントイ
ン、サリチル酸、ジプロピレングリコール、POE(24モル)
・POP(13モル)テ゛シルテトラテ゛シルエーテル、香料を溶解させた。次
に、精製水に乳酸、乳酸ナトリウム、色素を溶解させ、
エタノール部に加えた後、撹拌させ透明液状のローショ
ンを得た。
Example 12: Lotion Ingredients Weight% 95% Ethanol 75.0 Acetylated Hyaluronic Acid 0.3 Dipotassium Glycyrrhizinate 3.0 Allantoin 0.2 Salicylic Acid 0.01 Dipropylene Glycol 1.0 POE (24 Mol) / POP (13 mol) decyltetradecyl ether 0.5 lactic acid proper amount sodium lactate proper amount fragrance and dye proper amount purified water residue Production method: Dissolve acetylated hyaluronic acid in 95% ethanol, dipotassium glycyrrhizinate, allantoin, salicylic acid , Dipropylene glycol, POE (24 mol)
-POP (13 mol) decyl tetradecyl ether and perfume were dissolved. Next, lactic acid, sodium lactate, and pigment are dissolved in purified water,
After adding to the ethanol part, the mixture was stirred to obtain a clear liquid lotion.

【0035】 「実施例13:ローション」 配合成分 重量% 95%エタノール 60.0 アセチル化ヒアルロン酸 5.0 メントール 0.5 酸化亜鉛 0.1 塩化ベンザルコニウム 0.2 セリン 0.05 ポリエチレングリコール−400 1.0 POE硬化ヒマシ油(20モル) 1.0 リン酸 適量 香料および色素 適量 精製水 残分 製造方法:95%エタノールにアセチル化ヒアルロン酸
を溶解させ、メントール、アラントイン、ポリエチレン
グリコール−400、POE硬化ヒマシ油(20モ
ル)、香料を溶解させた。次に、精製水に酸化亜鉛を分
散させ、さらに塩化ベンザルコニウム、リン酸、色素を
溶解させ、エタノール部に加えた後、撹拌させ2層状の
ローションを得た。
Example 13: Lotion Ingredients Weight% 95% Ethanol 60.0 Acetylated Hyaluronic Acid 5.0 Menthol 0.5 Zinc Oxide 0.1 Benzalkonium Chloride 0.2 Serine 0.05 Polyethylene Glycol 400 1.0 POE hydrogenated castor oil (20 mol) 1.0 Phosphoric acid proper amount Flavor and pigment proper amount Purified water residue Production method: Dissolve acetylated hyaluronic acid in 95% ethanol, menthol, allantoin, polyethylene glycol-400, POE hydrogenated castor oil (20 mol) and perfume were dissolved. Next, zinc oxide was dispersed in purified water, and further, benzalkonium chloride, phosphoric acid, and a dye were dissolved. The solution was added to an ethanol portion, followed by stirring to obtain a two-layered lotion.

【0036】[0036]

【発明の効果】本発明によれば、優れた脱毛防止効果を
有し、さらにはフケ・カユミ防止効果にも優れている頭
皮頭髪用組成物を提供できる。
According to the present invention, it is possible to provide a composition for scalp hair which has an excellent effect of preventing hair loss and also an excellent effect of preventing dandruff and Kayumi.

Claims (5)

【特許請求の範囲】[Claims] 【請求項1】 アセチル化ヒアルロン酸と消炎剤とを含
有することを特徴とする頭皮頭髪用組成物。
1. A composition for scalp hair comprising acetylated hyaluronic acid and an anti-inflammatory agent.
【請求項2】 前記アセチル化ヒアルロン酸のアセチル
基の置換数が、下記化学式「化1」で表される繰り返し
構造単位において平均して2〜4であることを特徴とす
る請求項1記載の頭皮頭髪用組成物。 【化1】 (式中、R1、R2、R3、R4は水素またはエステル結合
されたアセチル基を意味し、且つ平均して各繰り返し構
造においてR1〜R4の少なくとも2以上がアセチル基で
ある。R5は水素またはアルカリ金属原子を示す。)
2. The acetylated hyaluronic acid according to claim 1, wherein the number of substitutions of the acetyl group in the repeating structural unit represented by the following chemical formula (Chemical Formula 1) is 2 to 4 on average. Composition for scalp hair. Embedded image (Wherein, R 1 , R 2 , R 3 , and R 4 each represent hydrogen or an acetyl group bonded through an ester bond, and on average, at least two or more of R 1 to R 4 in each repeating structure are acetyl groups. R 5 represents hydrogen or an alkali metal atom.)
【請求項3】 前記消炎剤が、グリチルレチン酸及びそ
の誘導体、グリチルリチン酸及びその誘導体、サリチル
酸及びその誘導体、オクトピロックス、酸化亜鉛、アラ
ントイン、塩化ベンザルコニウム、イソプロピルメチル
フェノール、メントールからなる群から選ばれた一種ま
たは二種以上であることを特徴とする請求項1または2
記載の頭皮頭髪用組成物。
3. The anti-inflammatory agent is selected from the group consisting of glycyrrhetinic acid and its derivatives, glycyrrhizic acid and its derivatives, salicylic acid and its derivatives, octopirox, zinc oxide, allantoin, benzalkonium chloride, isopropylmethylphenol and menthol. 3. One or two or more selected ones.
The composition for scalp hair according to the above.
【請求項4】 前記アセチル化ヒアルロン酸の含有量が
頭皮頭髪用組成物全量に対して0.001〜10重量%
であることを特徴とする請求項1、2または3記載の頭
皮頭髪用組成物。
4. The content of the acetylated hyaluronic acid is 0.001 to 10% by weight based on the total amount of the scalp hair composition.
The composition for scalp hair according to claim 1, 2, or 3.
【請求項5】 前記消炎剤の含有量が頭皮頭髪用組成物
全量に対して0.001〜5重量%であることを特徴と
する請求項1、2、3または4記載の頭皮頭髪用組成
物。
5. The composition for scalp hair according to claim 1, wherein the content of the anti-inflammatory agent is 0.001 to 5% by weight based on the total amount of the composition for scalp hair. Stuff.
JP36340097A 1997-12-16 1997-12-16 Composition for scalp and hair Withdrawn JPH11180832A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP36340097A JPH11180832A (en) 1997-12-16 1997-12-16 Composition for scalp and hair

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP36340097A JPH11180832A (en) 1997-12-16 1997-12-16 Composition for scalp and hair

Publications (1)

Publication Number Publication Date
JPH11180832A true JPH11180832A (en) 1999-07-06

Family

ID=18479219

Family Applications (1)

Application Number Title Priority Date Filing Date
JP36340097A Withdrawn JPH11180832A (en) 1997-12-16 1997-12-16 Composition for scalp and hair

Country Status (1)

Country Link
JP (1) JPH11180832A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001213724A (en) * 2000-02-03 2001-08-07 Shiseido Co Ltd Double layer type cosmetic
JP2004262777A (en) * 2003-02-27 2004-09-24 Shiseido Co Ltd Acetylated hyaluronic acid-containing ocular medicinal preparation
EP2943180B1 (en) * 2013-01-10 2019-09-04 L'Oréal Soothing cosmetic composition based on salicylic acid
CN111329795A (en) * 2020-04-02 2020-06-26 华熙生物科技股份有限公司 Hair-blacking and hair-nourishing composition, application thereof and preparation method of hair-blacking and hair-nourishing product

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001213724A (en) * 2000-02-03 2001-08-07 Shiseido Co Ltd Double layer type cosmetic
JP2004262777A (en) * 2003-02-27 2004-09-24 Shiseido Co Ltd Acetylated hyaluronic acid-containing ocular medicinal preparation
EP2943180B1 (en) * 2013-01-10 2019-09-04 L'Oréal Soothing cosmetic composition based on salicylic acid
CN111329795A (en) * 2020-04-02 2020-06-26 华熙生物科技股份有限公司 Hair-blacking and hair-nourishing composition, application thereof and preparation method of hair-blacking and hair-nourishing product
CN111329795B (en) * 2020-04-02 2023-03-21 华熙生物科技股份有限公司 Hair-blacking and hair-nourishing composition, application thereof and preparation method of hair-blacking and hair-nourishing product

Similar Documents

Publication Publication Date Title
JP2001288043A (en) Composition for scalp and hair
JP2002173449A (en) Hair-growing agent
JP2000169320A (en) Cell activation agent and preparation for external use for skin and skin cleaning agent containing the activation agent
WO1989002731A1 (en) Hair tonic
JPH11180832A (en) Composition for scalp and hair
JPH11269043A (en) Cosmetic for scalp and hair
JPH11180833A (en) Composition for scalp and hair
JPH11236319A (en) Composition for scalp and hair
JP2001131031A (en) Composition for scalp and hair
JP2001288045A (en) Composition for scalp and hair
JP2001288046A (en) Composition for scalp and hair
JPH1171234A (en) Skin preparation for external use
JP3483984B2 (en) Cosmetics
JP3912722B2 (en) Topical skin preparation
JP2004315442A (en) Gray hair-preventing/improving agent
JPH10279421A (en) Preparation for external use for skin
JPH11302133A (en) Cosmetic for scalp and hair
JPH08157337A (en) Hair cosmetic
JP2000044436A (en) Composition for scalp and hair treatment
JPH10273424A (en) Cosmetic for hair
JPH10273423A (en) Cosmetic for hair
JP3001942B2 (en) Skin cosmetics
JP2001288042A (en) Composition for scalp and hair
JP2001072567A (en) Skin cosmetic
JPH10147514A (en) Cosmetic

Legal Events

Date Code Title Description
A300 Withdrawal of application because of no request for examination

Free format text: JAPANESE INTERMEDIATE CODE: A300

Effective date: 20050301